Natco Pharma (India) Today
| NATCOPHARM | 1,337 13.80 1.02% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Natco Pharma is trading at 1337.45 as of the 29th of November 2024. This is a 1.02 percent decrease since the beginning of the trading day. The stock's open price was 1351.25. Natco Pharma has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Natco Pharma Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2024 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Natco Pharma is entity of India. It is traded as Stock on NSE exchange. The company has 179.11 M outstanding shares. More on Natco Pharma Limited
Moving against Natco Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Natco Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Natco Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Natco Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | Rajeev Nannapaneni | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Natco Pharma's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Natco Pharma's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsNatco Pharma can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Natco Pharma's financial leverage. It provides some insight into what part of Natco Pharma's total assets is financed by creditors.
| |||||
Natco Pharma Limited (NATCOPHARM) is traded on National Stock Exchange of India in India and employs 4,016 people. Natco Pharma is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 239.55 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Natco Pharma's market, we take the total number of its shares issued and multiply it by Natco Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Natco Pharma Limited operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 179.11 M outstanding shares.
Natco Pharma Limited has accumulated about 4.14 B in cash with 12.52 B of positive cash flow from operations.
Check Natco Pharma Probability Of Bankruptcy
Ownership AllocationNatco Pharma Limited maintains a total of 179.11 Million outstanding shares. Natco Pharma Limited holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Natco Ownership Details
Natco Pharma Limited Risk Profiles
Although Natco Pharma's alpha and beta are two of the key measurements used to evaluate Natco Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.33 | |||
| Standard Deviation | 1.67 | |||
| Variance | 2.79 | |||
| Risk Adjusted Performance | (0.1) |
Natco Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Natco Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Natco Pharma Corporate Directors
| Pavan Bhat | Executive Director | Profile | |
| Bhimavarapu Reddy | Director FDF | Profile | |
| MS Pharm | MD Director | Profile | |
| Potluri Prasad | Executive Director | Profile |
Other Information on Investing in Natco Stock
Natco Pharma financial ratios help investors to determine whether Natco Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Natco with respect to the benefits of owning Natco Pharma security.